首页> 美国卫生研究院文献>The Indian Journal of Medical Research >Association of serotonin transporter (SLC6A4) receptor (5HTR1A 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study
【2h】

Association of serotonin transporter (SLC6A4) receptor (5HTR1A 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study

机译:抑郁症患者血清5-羟色胺转运蛋白(SLC6A4)和受体(5HTR1A5HTR2A)多态性与依他普仑治疗反应的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background & objectives:Genetic factors have potential of predicting response to antidepressants in patients with major depressive disorder (MDD). In this study, an attempt was made to find an association between response to escitalopram in patients with MDD, and serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms.
机译:背景与目的:遗传因素有可能预测重度抑郁症(MDD)患者对抗抑郁药的反应。在这项研究中,试图找到MDD患者对依西酞普兰的反应与血清素转运蛋白(SLC6A4)和受体(5HTR1A,5HTR2A)多态性之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号